International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025. ISBN: 978-2-930229-96-6. pp: 1-125.

American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes: 2026. Diabetes Care. 2026;49 (Suppl 1):S1-S371.

Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36.

Article  PubMed  Google Scholar 

Wong TY, Cheung CMG, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012.

Article  PubMed  Google Scholar 

Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64.

Article  PubMed  PubMed Central  Google Scholar 

Lim JI et al. Diabetic Retinopathy Preferred Practice Pattern. Ophthalmology. 2025;132:75-162.

Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018.

Article  PubMed  PubMed Central  Google Scholar 

Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among adults with diabetes. JAMA. 2016;316:602–10.

Article  PubMed  PubMed Central  Google Scholar 

American Diabetes Association Professional Practice Committee. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes: 2026. Diabetes Care. 2026;49 (Suppl 1):S246-S260.

Kidney Disease. Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105:S117–314.

Article  Google Scholar 

Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–25.

Article  CAS  PubMed  Google Scholar 

Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88.

Article  CAS  PubMed  Google Scholar 

Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–86.

Article  PubMed  Google Scholar 

Wong TY, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction. J Am Soc Nephrol. 2004;15:2469–76.

Article  PubMed  Google Scholar 

Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29:1802–9.

Article  CAS  PubMed  Google Scholar 

Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.

Looker HC, Mauer M, Nelson RG. Role of kidney biopsies for biomarker discovery in diabetic kidney disease. Adv Chronic Kidney Dis. 2018;25:192–201.

Article  PubMed  PubMed Central  Google Scholar 

Selvin E, Steffes MW, Zhu H, et al. Glycated haemoglobin, diabetes, and cardiovascular risk. N Engl J Med. 2010;362:800–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambers Heerspink HJ, Gansevoort RT, Brenner BM, et al. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol. 2010;21:1355–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meri S, Morgan BP, Davies A, et al. Human protectin CD59, an inhibitor of membrane attack complex formation. Immunology. 1990;71:1–9.

CAS  PubMed  PubMed Central  Google Scholar 

Qin X, Goldfine A, Krumrei N, et al. Glycation inactivation of the complement regulatory protein CD59: a possible role in vascular complications of human diabetes. Diabetes. 2004;53:2653–61.

Article  CAS  PubMed  Google Scholar 

Davies CS, Harris CL, Morgan BP. Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects. Immunology. 2005;114:280–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh P, Sahoo R, Vaidya A, et al. Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humans. J Clin Endocrinol Metab. 2014;99:E999–1006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017;13:311–8.

Article  CAS  PubMed  Google Scholar 

Sun Z, et al. Complement activation in diabetic retinopathy and diabetic kidney disease. Front Immunol. 2022;13:894077.

Google Scholar 

Halperin JA, et al. Role of complement and glycated CD59 in the complications of diabetes. Clin Immunol. 2015;161:174–83.

Google Scholar 

Ghosh P, Luque-Fernandez MA, Vaidya A, et al. Plasma glycated CD59 as a novel biomarker for detection of gestational diabetes mellitus. Diabetes Care. 2017;40:981–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bogdanet D, Reddin C, Murphy D, et al. Plasma glycated CD59 as an early biomarker for gestational diabetes mellitus. BMJ Open. 2022;12:e054773.

Article  Google Scholar 

Yilmaz O, Erinc K, et al. The relationship of plasma glycated CD59 level with microvascular complications in type 2 diabetes mellitus. J Clin Med. 2025;14:4588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Busik JV, Mohr S, Grant MB. Hyperglycaemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008;57:1952–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in diabetic nephropathy. Nat Rev Nephrol. 2011;7:327–40.

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.

Article  Google Scholar 

American Diabetes Association Professional Practice Committee;. Introduction and methodology: Standards of Care in Diabetes: 2026. Diabetes Care. 2026;49(Suppl 1):S1-S5 .

Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.

Article  CAS  PubMed  Google Scholar 

Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic colour fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5 Suppl):786–806.

Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4 Suppl):S117–S314.

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49.

Article  CAS  PubMed  PubMed Central  Google Scholar